Gastric disorder and Aspartate aminotransferase abnormal

Summary:

Aspartate aminotransferase abnormal is reported only by a few people with Gastric disorder.

The study analyzes which people have Aspartate aminotransferase abnormal with Gastric disorder. It is created by eHealthMe based on 2 people who have Aspartate aminotransferase abnormal and Gastric disorder from the Food and Drug Administration (FDA), and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

2 people who have Gastric Disorder and Aspartate Aminotransferase Abnormal are studied.


What is Gastric disorder?

Gastric disorder (disease of stomach) is found to be associated with 1,618 drugs and 1,202 conditions by eHealthMe.

What is Aspartate aminotransferase abnormal?

Aspartate aminotransferase abnormal is found to be associated with 603 drugs and 349 conditions by eHealthMe.

Number of Aspartate aminotransferase abnormal in Gastric disorder reports submitted per year:

Would you have Aspartate aminotransferase abnormal when you have Gastric disorder?

Gender of people who have Gastric Disorder and experienced Aspartate Aminotransferase Abnormal *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Gastric Disorder and experienced Aspartate Aminotransferase Abnormal *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 50.00%
  2. Pleural Effusion (water on the lungs): 1 person, 50.00%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 50.00%
  4. Gastritis (inflammation of stomach): 1 person, 50.00%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 50.00%
  6. Depression: 1 person, 50.00%
  7. Arrhythmias (irregular heartbeat): 1 person, 50.00%
  8. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 50.00%

Common drugs taken by these people *:

  1. Humira: 2 people, 100.00%
  2. Vitamin B2: 1 person, 50.00%
  3. Pantoprazole: 1 person, 50.00%
  4. Nexium: 1 person, 50.00%
  5. Escitalopram: 1 person, 50.00%

Common symptoms for these people *:

  1. Gastritis (inflammation of stomach): 2 people, 100.00%
  2. Transaminases Abnormal: 1 person, 50.00%
  3. Tendonitis (a condition that causes pain and swelling of tendons): 1 person, 50.00%
  4. Bladder Disorder: 1 person, 50.00%
  5. Blood Insulin Increased: 1 person, 50.00%
  6. Burning Sensation: 1 person, 50.00%
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 1 person, 50.00%
  8. Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 1 person, 50.00%
  9. Gamma-Glutamyltransferase Abnormal: 1 person, 50.00%
  10. Immunodeficiency: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Aspartate aminotransferase abnormal?

Check whether Aspartate aminotransferase abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Aspartate aminotransferase abnormal:

All the drugs that are associated with Aspartate aminotransferase abnormal:

All the conditions that are associated with Aspartate aminotransferase abnormal:

How the study uses the data?

The study is based on Aspartate aminotransferase abnormal and Gastric disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: